Left ventricle remodeling in men with moderate to severe volume-dependent hypertension

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 13, Issue 4, 2012, Pages 426-434

  Indra, Tomáš ^a,b   Holaj, Robert ^a,b   Zelinka, Tomáš ^a,b   Petrák, Ondřej ^a,b   Štrauch, Branislav ^a,b   Rosa, Ján ^a,b   Šomlóová, Zuzana ^a,b   Malík, Jan ^a,b   Janota, Tomáš ^a,b   Hradec, Jaromír ^a,b   Widimský, Jiří ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

echocardiography; heart remodeling; primary aldosteronism; renin angiotensin aldosterone system; Volume dependent hypertension

Indexed keywords

ALDOSTERONE; POTASSIUM; RENIN; SODIUM;

ADULT; ALDOSTERONE BLOOD LEVEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE REMODELING; HEART LEFT VENTRICLE SIZE; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; HYPERTROPHY; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIMARY HYPERALDOSTERONISM; PROTEIN BLOOD LEVEL; RESISTANT HYPERTENSION; SALT INTAKE; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL;

ANTIHYPERTENSIVE AGENTS; ELECTROCARDIOGRAPHY; HEART VENTRICLES; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; PLASMA VOLUME; RENIN; VENTRICULAR REMODELING;

EID: 84870006395     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320312446240     Document Type: Article

References (45)

1. Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006 ; 48: 2293-2300
2. Štrauch B, Zelinka T, Hampf M, et al. Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region. J Hum Hypertens. 2003 ; 17: 349-352
3. Milliez P, Girerd X, Plouin P-F, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005 ; 45: 1243-1248
4. Catena C, Colussi G, Nadalini E, et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med. 2008 ; 168: 80-85
5. Weber K, Brilla C. Pathological hypertrophy and cardiac intersticium fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991 ; 83: 1849-1865
6. Muiesan ML, Salvetti M, Paini A, et al. Inappropriate left ventricular mass in patients with primary aldosteronism. Hypertension. 2008 ; 52: 529-534
7. Rossi GP, Sacchetto A, Visentin P, et al. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension. 1996 ; 27: 1039-1045
8. Matsumura K, Fujii K, Oniki H, et al. Role of aldosterone in left ventricular hypertrophy in hypertension. Am J Hypertens. 2006 ; 19: 13-18
9. Goldkorn R, Yurenev A, Blumenfeld J, Fishman D, Devereux RB. Echocardiographic comparison of left ventricular structure and function in hypertensive patients with primary aldosteronism and essential hypertension. Am J Hypertens. 2002 ; 15: 340-345
10. Yoshihara F, Nishikimi T, Yoshitomi Y, et al. Left ventricular structural and functional characteristics in patients with renovascular hypertension, primary aldosteronism and essential hypertension. Am J Hypertens. 1996 ; 9: 523-528
11. Shigematsu Y, Hamada M, Okayama H, et al. Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism. Hypertension. 1997 ; 29: 723-727
12. Gaddam K, Corros C, Pimenta E, et al. Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism. Hypertension. 2010 ; 55: 1137-1142
13. Egan BM, Basile JN, Rehman SU, et al. Plasma renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial. Am J Hypertens. 2009 ; 22: 792-801
14. Vasan RS, Evans JC, Benjamin EJ, et al. Relations of serum aldosterone to cardiac structure. Hypertension. 2004 ; 43: 957-962
15. Newton-Cheh C, Guo C-Y, Gona P, et al. Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. Hypertension. 2007 ; 49: 846-856
16. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension. Eur Heart J. 2007 ; 28: 1462-1536
17. Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008 ; 93: 3266-3281
18. Holland O, Brown H, Kuhnert L, et al. Further evaluation of saline infusion for the diagnosis of primary aldosteronism. Hypertension. 1984 ; 6: 717-723
19. Giacchetti G, Ronconi V, Lucarelli G, et al. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol. J Hypertens. 2006 ; 24: 737-745
20. Rossi GP, Belfiore A, Bernini G, et al. Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension. 2007 ; 50: 424-431
21. Mulatero P, Verhovez A, Morello F, et al. Diagnosis and treatment of low-renin hypertension. Clin Endocrinol. 2007 ; 67: 324-334
22. Sahn DJ, DeMaria A, Kisslo J, et al. The Committee on M-Mode Standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurement. Circulation. 1978 ; 58: 1072-1083
23. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005 ; 18: 1440-1463
24. Gosse P, Jullien V, Jarnier P, et al. Echocardiographic definition of left ventricular hypertrophy in the hypertensive: which method of indexation of left ventricular mass?. J Hum Hypertens. 1999 ; 13: 505-509
25. Maule S, Mulatero P, Milan A, et al. QT interval in patients with primary aldosteronism and low-renin essential hypertension. J Hypertens. 2006 ; 24: 2459-2464
26. Gaddam KK, Nishizaka MK, Pratt-Ubunama MN, et al. Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion. Arch Intern Med. 2008 ; 168: 1159-1164
27. Jakubik P, Janota T, Widimsky J, et al. Impact of essential hypertension and primary aldosteronism on plasma brain natriuretic peptide concentration. Blood Press. 2006 ; 15: 302-307
28. Pimenta E, Gordon RD, Ahmed AH, et al. Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study. J Clin Endocrinol Metab. 96: 2813-2820
29. Makhanova N, Hagaman J, Kim H-S, et al. Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase. Hypertension. 2008 ; 51: 134-140
30. Rossi GP, Di Bello V, Ganzaroli C, et al. Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. Hypertension. 2002 ; 40: 23-27
31. Muscholl MW, Schunkert H, Muders F, et al. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension. Am Heart J. 1998 ; 135: 58-66
32. Iwashima Y, Horio T, Kuroda S, et al. Influence of plasma aldosterone on left ventricular geometry and diastolic function in treated essential hypertension. Hypertens Res. 2002 ; 25: 49-56
33. Rossi GP, Sacchetto A, Pavan E, et al. Remodeling of the left ventricle in primary aldosteronism due to conn's adenoma. Circulation. 1997 ; 95: 1471-1478
34. Stowasser M, Sharman J, Leano R, et al. Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab. 2005 ; 90: 5070-5076
35. Kozakova M, Buralli S, Palombo C, et al. Myocardial ultrasonic backscatter in hypertension: relation to aldosterone and endothelin. Hypertension. 2003 ; 41: 230-236
36. Edelmann F, Tomaschitz A, Wachter R, et al. Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fraction. Eur Heart J. 2012 ; 33 (2). 203-212
37. Rizzoni D, Muiesan ML, Porteri E, et al. Relations between cardiac and vascular structure in patients with primary and secondary hypertension. J Ameri Coll Cardiol. 1998 ; 32: 985-992
38. Catena C, Colussi G, Lapenna R, et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension. 2007 ; 50: 911-918
39. Pierdomenico SD, Di Nicola M, Pierdomenico AM, et al. Cardiovascular risk in subjects with left ventricular concentric remodeling at baseline examination: a meta-analysis. J Hum Hypertens. 2011 ; 25 (10). 585-591
40. de Simone G, Izzo R, Chinali M, et al. Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension?. Hypertension. 2010 ; 56: 99-104
41. Holaj R, Zelinka T, Wichterle D, et al. Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension. J Hypertens. 2007 ; 25: 1451-1457
42. Holaj R, Widimský J. Increased carotid intima-media thickness in hypertensive patients with a high aldosterone/plasma renin activity ratio and elevated aldosterone plasma concentration. J Hypertens. 2008 ; 26: 1500-1501
43. Guyton AC. Kidneys and fluids in pressure regulation. Small volume but large pressure changes. Hypertension. 1992 ; 19: I2 - I8
44. Pouleur A-C, le Polain de Waroux J-B, Pasquet A, et al. Assessment of left ventricular mass and volumes by three-dimensional echocardiography in patients with or without wall motion abnormalities: comparison against cine magnetic resonance imaging. Heart. 2008 ; 94: 1050-1057
45. Myerson SG, Montgomery HE, World MJ, et al. Left ventricular mass: reliability of m-mode and 2-dimensional echocardiographic formulas. Hypertension. 2002 ; 40: 673-678